BackCrescent Capital BDC Overview

Crescent Capital BDC EBIT

Track Crescent Capital BDC's EBIT ($35M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$13.60M

As of Jun 30, 2026

Annual EBIT (TTM)

$35.15M

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Crescent Capital BDC (CCAP) FAQ

As of the most recent data (June 2026), CCAP shows a EBIT of $35M. In the prior-year period, the figure was $0. That is below the Finance sector average of $330B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CCAP's EBIT is now $35M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Crescent Capital BDC is outperforming or lagging.

The Finance sector average EBIT is about $330B. Crescent Capital BDC is at $35M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how CCAP stacks up against individual peers as well.

Tracking CCAP's ebit over time shows whether Crescent Capital BDC is scaling, shrinking, or reshaping that part of the business. The current reading is $35M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Crescent Capital BDC's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $35M) with ownership activity and broader fundamentals.